Pain reducing drug administration during surfactant therapy by less invasive technique . Surfactant are alveolar surface reducing agents,used in baby having lower pool surfactant i.e. respiratory distress syndrome.
Not Applicable
- Conditions
- Health Condition 1: P220- Respiratory distress syndrome of newborn
- Registration Number
- CTRI/2020/08/027144
- Lead Sponsor
- IPGMER SSKM HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 34
Inclusion Criteria
Preterm baby with gestational age between 28 to 34 weeks diagnosed with RDS will enroll in this study . RDS will be diagnosed clinically initially and later confirm by chest X ray .
A written informed consent will be obtained from the parents of the baby for participation in the study
Exclusion Criteria
Baby with major congenital anomaly .
Perinatal asphyxia (cord blood pH <7.2).
Intubated at delivery room.
Alternative cause of respiratory distress.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method